Cetera Advisor Networks LLC Innoviva, Inc. Transaction History

Cetera Advisor Networks LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$14.32 - $19.88 $184,112 - $255,597	-12,857 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$15.39 - $20.25 $197,869 - $260,354	12,857 New	12,857 $249,000
Q3 2020 Nov 13, 2020	SELL	$10.33 - $14.49 $3,326 - $4,665	-322 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$11.49 - $15.26 $3,699 - $4,913	322 New	322 $5,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.